EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

CD39 is Expressed by a Wide Range of Cutaneous T-Cell Lymphomas

Gilles Battesti, Nicolas Thonnart, Alizée Bozonnat, Caroline Ram-Wolff, Adèle de Masson, Armand Bensussan, Martine Bagot, Anne Marie-Cardine, Maxime Battistella

Skin Health and Disease · 2024-04-01 · 4 (2)

DOI: 10.1002/ski2.334 ↗
AstrattDettalji biblijografiċi

Astratt

CD39, an ectoenzyme in the immunosuppressive CD39/CD73/adenosine pathway, known to promote solid tumour outgrowth and spreading, was investigated in both skin and blood compartments of cutaneous T cell lymphomas. CD39 was overexpressed by peripheral blood T-cells in Sezary syndrome and mycosis fungoides, and in skin-infiltrating lymphocytes of Sezary syndrome, mycosis fungoides, subcutaneous panniculitis-like T-cell lymphoma and primary cutaneous CD30-positive lymphoproliferation. Our study emphasizes the interest in using CD39/CD73/adenosine pathway blocking agents for cutaneous T cell lymphomas treatment.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →